Search research articles
Contact Us
Filters
Showing results (101-110 of 192) with videos related to
Page
of 20
Sort By:
Journal of Women & Aging
|
January 26, 2018
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience
Paola Vitiello, Lucia Taramasso, Elena Ricci, et al.
The Journal of Antimicrobial Chemotherapy
|
October 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort
Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2010
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens
Daniel Gonzalez de Requena, Stefano Bonora, Ottavia Viganò, et al.
Antiviral Therapy
|
October 3, 2018
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, et al.
Antiviral Therapy
|
April 26, 2003
Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes
Elisabetta Chiesa, Teresa Bini, Fulvio Adorni, et al.
Antiviral Research
|
October 21, 2019
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference
Andrea Giacomelli, Alessia Lai, Marco Franzetti, et al.
The Annals of Pharmacotherapy
|
February 28, 2018
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data
Amedeo Ferdinando Capetti, Maria Vittoria Cossu, Gaetana Sterrantino, et al.
Journal of Hypertension
|
January 4, 2013
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study
Giuseppe Schillaci, Paolo Maggi, Giordano Madeddu, et al.
Pathogens (Basel, Switzerland)
|
March 6, 2021
Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy
Gabriele Pagani, Alessia Lai, Annalisa Bergna, et al.
Viruses
|
March 30, 2023
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
Pierluigi Francesco Salvo, Damiano Farinacci, Arturo Ciccullo, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 192) with videos related to
Sort By:
Page
of 20
Journal of Women & Aging
|
January 26, 2018
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience
Paola Vitiello, Lucia Taramasso, Elena Ricci, et al.
The Journal of Antimicrobial Chemotherapy
|
October 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort
Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2010
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens
Daniel Gonzalez de Requena, Stefano Bonora, Ottavia Viganò, et al.
Antiviral Therapy
|
October 3, 2018
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, et al.
Antiviral Therapy
|
April 26, 2003
Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes
Elisabetta Chiesa, Teresa Bini, Fulvio Adorni, et al.
Antiviral Research
|
October 21, 2019
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference
Andrea Giacomelli, Alessia Lai, Marco Franzetti, et al.
The Annals of Pharmacotherapy
|
February 28, 2018
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data
Amedeo Ferdinando Capetti, Maria Vittoria Cossu, Gaetana Sterrantino, et al.
Journal of Hypertension
|
January 4, 2013
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study
Giuseppe Schillaci, Paolo Maggi, Giordano Madeddu, et al.
Pathogens (Basel, Switzerland)
|
March 6, 2021
Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy
Gabriele Pagani, Alessia Lai, Annalisa Bergna, et al.
Viruses
|
March 30, 2023
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
Pierluigi Francesco Salvo, Damiano Farinacci, Arturo Ciccullo, et al.
Page
of 20